Contributor Page
Singh & Associates
 
Email  |  Website  |  Articles
Contact Details
Tel: +91 11 46667000
Fax: +91 11 46667001
E-337, East of Kailash
New Delhi
110065
India
Awards
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
Contributor Most Read
By Singh & Associates
This release is an advance preview that will allow countries to plan how to use the new version, prepare translations, and train health professionals all over the country.
By Singh & Associates
Kymriah will be available as a dispersion for infusion.
By Singh & Associates
IRIS is the online web portal through which applicants can apply to the EMA for orphan designation for a medicine.
By Singh & Associates
The Ministry of Health and Family Welfare, on March 16, 2018, has notified that tuberculosis is a dangerous epidemic disease, a threat to life and is a major public health problem accounting...
By Singh & Associates
The Office of the Registrar General, India, under the Ministry of Home Affairs, has released special Sample Registration System (SRS) Bulletin on Maternal Mortality in India 2014-2016.
By Singh & Associates
On June 19, 2018, Strides Shasun announced the receipt of prequalification from the World Health Organization for their 100mg Rectal Artesunate Suppositories for the pre-referral management of severe malaria.
By Singh & Associates
The Competition Commission of India (CCI) is an administrative or regulatory body formed under the Competition Act 2002 (as amended vide Competition (Amendment) Act 2007, and hereinafter referred to as the ‘Act").
By Singh & Associates
There was a significant jump witnessed in India's ease of doing business rankings last year and the Insolvency and Bankruptcy code ("the Code") was regarded as a key contributor in the jump.
By Harsimran Singh
The present write up1 is to collate and present highlights of recent reforms introduced by the Government of India and its various instrumentalities for making ...
By Tushar Roy
The Hon'ble Supreme Court, in Devidayal Castings Private Limited vs. Haryana Financial Corporation and Ors. has decided an issue as laid down here ...
By Mahip Singh Sikarwar
Specific Performance is mostly sought in case of a breach of contract resulting in damages or losses for one of the parties to the contract.
By Singh & Associates
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib) combination for the treatment of anaplastic thyroid cancer (ATC) ...
By Singh & Associates
On May 17, 2018, USFDA Commissioner Scott Gottlieb issued a statement saying, "no patients should be priced out of medicines they need to support their health.
By Singh & Associates
On May 17, 2018, the United States Food and Drug Administration (USFDA) has approved Aimovig (erenumabaooe) for preventive treatment of migraine in adults.
By Singh & Associates
On May 18, 2018, the European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) concluded two referrals for Zinbryta (daclizumab beta) and Esmya (ulipristal acetate) ...
Contributor's Topics
More...